Even when its clot-dissolving powers are removed, the stroke drug tPA can still protect brain cells from the loss of oxygen and glucose induced by a stroke, researchers have discovered. The finding ...

NICE, France — Treating patients with thrombolysis should not be based purely on time, and a stronger predictor of who will benefit most is the amount of dead tissue in the brain as visible on ...

About 87 percent of all strokes are ischemic, meaning they’re caused by a blood clot in the brain. For more than 20 years, the standard of care has been a drug called TPA. But now, some doctors are ...

A study may lead to a significant expansion in the number of stroke patients who can safely be treated with intravenous tPA, the 'clot busting' drug that has greatly reduced stroke-related disability ...

The first multicenter study to look at treatments for post-thrombolysis symptomatic intracerebral hemorrhage (ICH) has not shown any significant benefit of using any therapy (mainly cryoprecipitate) ...

Emergency room physicians can deliver clot-busting treatments to a wider range of stroke patients than previously thought, European researchers report in the Sept. 25 New England Journal of Medicine.

The window of safety and efficacy for administering tissue plasminogen activator (tPA), the only FDA-approved medication for stroke, is less than four hours. For patients with “wake-up stroke,” ...

BOSTON (CBS) - We first told you about the drug tPA (tissue plasminogen activator) last week. Doctors at Beth Israel Deaconess Medical Center are using tPA off-label on critically ill COVID-19 ...

It is a tiny vacuum cleaner for the brain: A new treatment for stroke victims promises to suction out clogged arteries in hopes of stopping the brain attack before it does permanent harm. Called ...

A new study published online in the Journal of Trauma and Acute Care Surgery in March 2020 reports that the anticoagulation drug tPA could be a potential aid in managing respiratory failure in ...

A study led by Massachusetts General Hospital (MGH) investigators may lead to a significant expansion in the number of stroke patients who can safely be treated with intravenous tPA (tissue ...